Advanced Therapies Inc is a privately-held drug delivery company pioneering a new therapeutic delivery system, Artificial Viral Envelopes (AVEs). By mimicking naturally occurring viral envelopes, AVEs are able to recognize and enter targeted cells with the high selectively and efficiency of natural viruses. Readily manufactured and capable of being administered via all the major physiologic pathways, AVEs can transport drugs, immunotoxins, proteins, peptides and enzymes as well as gene and gene constructs into cells associated with specific diseases. Advanced Therapies Inc is seeking strategic partnerships with pharmaceutical and biotechnology firms for the commercialization of innovative therapies
